Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Diabetic Nephropathy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating CCX140-B for safety and efficacy in diabetic nephropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Type 2 Diabetes Mellitus

Drugs mentioned

• CCX140-B (CCX140-B)

Snippet

Sponsor: Amgen | Conditions: Diabetic Nephropathy, Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED